Anna Galea is a Principal Scientist with extensive experience in analytical development and mass spectrometry, currently serving as Manager of Mass Spectrometry at Fresenius Kabi. They previously held leadership roles at Ichnos Sciences and Ichnos Glenmark Innovation, focusing on the characterization of biotherapeutics. Anna earned a PhD in Cell and Molecular Biology from the University of Bologna, where they developed analytical tools for vaccine characterization. With a background in microbiology and a strong emphasis on patient-centered drug development, Anna is now seeking new opportunities in the pharmaceutical industry.
This person is not in the org chart
This person is not in any teams
This person is not in any offices